Anteris Technologies Global Corp.
AVR Healthcare Medical Instruments & Supplies
Anteris Technologies Global Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 million, down 29.2% from fiscal 2024. In the quarter to June 2026, revenue grew 63.3%, EPS grew 48.3%, free cash flow fell 6.84% and total debt rose 8.15%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow AVR
Anteris Technologies Global Corp. (AVR) Beneish M-score
Anteris Technologies Global Corp.'s Beneish M-score for fiscal 2025 is −6.30; values above −1.78 are the model's flag for possible earnings manipulation — a statistical screen, not a finding.
Beneish M-score, annual
Embed this chart
Annual newest first
| Period | Beneish M-score | Change (points) |
|---|---|---|
| FY2025 | −6.30 | (2.02) |
| FY2024 | −4.28 | — |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Days’ sales in receivables index | 0.22 | — | 0.20 | |
| Gross margin index | 0.67 | — | 0.35 | |
| Asset quality index | 5.67 | — | 2.29 | |
| Sales growth index | 0.71 | — | 0.63 | |
| Depreciation index | 1.00 | — | 0.11 | |
| SG&A index | 1.31 | — | −0.23 | |
| Total accruals to total assets | (0.71) | — | −3.34 | |
| Leverage index | 4.53 | — | −1.48 | |
| Beneish M-score | Low — no pattern the model associates with manipulation | −6.30 | ||
How the Beneish M-score works
M = −4.84 + 0.920 × DSRI + 0.528 × GMI + 0.404 × AQI + 0.892 × SGI + 0.115 × DEPI − 0.172 × SGAI + 4.679 × TATA − 0.327 × LVGI (Beneish, 1999): eight changes in the accounts from one fiscal year to the next, which the model weighs for the pattern seen in companies that later restated their earnings. Higher is worse.
| below −2.22 | Low — no pattern the model associates with manipulation |
|---|---|
| −2.22 to −1.78 | Elevated |
| above −1.78 | Flagged by the model |
−1.78 is the cut-off usually quoted from the paper, −2.22 a common conservative one. A statistical screen, not a finding of wrongdoing.
When asset quality, depreciation or SG&A cannot be worked out, that index is set to 1, as Beneish did, and the breakdown says so; with all three missing there is no score. Depreciation includes amortisation, and asset quality leaves out securities. Not worked out for banks, insurers and REITs.
Beneish M-score against peers
| Company | Beneish M-score |
|---|---|
| AVR Anteris Technologies Global Corp. | −6.3× |
| STAA STAAR Surgical Company compare | −3.3× |
| SMTI Sanara MedTech Inc. compare | −3.2× |
| EMBC Embecta Corp. compare | −3.1× |
| ANGO AngioDynamics, Inc. compare | −3.1× |
| OSUR OraSure Technologies, Inc. compare | −2.7× |
| AZTA Azenta, Inc. compare | −2.6× |
| ZJYL Jin Medical International Ltd. compare | −2.5× |
| NNNN Anbio Biotechnology compare | 2.0× |
What Beneish M-score is
The Beneish M-Score combines eight year-on-year changes in the accounts into a statistical screen for patterns seen in companies that overstated earnings.
−4.84 + 0.920 × DSRI + 0.528 × GMI + 0.404 × AQI + 0.892 × SGI + 0.115 × DEPI − 0.172 × SGAI + 4.679 × TATA − 0.327 × LVGI